@AlCp
OPT had very promising ph2 trial results. Then both ph3 trials failed.
Far more biotechs fail than succeed, IMU is no different in this respect.
These companies are too risky to me as investments (unless you're gambling just a very small % of one's portfolio).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.2¢ | $304.8K | 23.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 57 | 13718532 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 5374446 | 13 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |